BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06679101-completion@plaintrial.com
DTSTAMP:20261027T024023Z
DTSTART;VALUE=DATE:20310331
SUMMARY:A Study of Belantamab Mafodotin Administered in Combination With Le
 nalidomide and Dexamethasone (BRd) Versus Daratumumab\, Lenalidomide\, and
  Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma
  (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-ND
 MM) — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06679101
URL:https://plaintrial.com/trial/NCT06679101
END:VEVENT
END:VCALENDAR
